Biogen Idec of Cambridge and Stockholm-based drug developer Swedish Orphan Biovitrum announced positive results today from a clinical study of a treatment for hemophilia A, a rare inherited disorder that impairs blood clotting.
A total of 165 male patients, aged 12 years and older, were enrolled in the study. Additional analyses of the study are ongoing, and the companies said they anticipate presenting detailed results at a future scientific meeting.
Biogen added that it plans to submit a biologics license application to the U.S. Food and Drug Administration in the first half of 2013.
Anda sedang membaca artikel tentang
Biogen sees positive results from drug study
Dengan url
http://emberemas.blogspot.com/2012/11/biogen-sees-positive-results-from-drug.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Biogen sees positive results from drug study
namun jangan lupa untuk meletakkan link
Biogen sees positive results from drug study
sebagai sumbernya
0 komentar:
Posting Komentar